Marcin Frąckiewicz

Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company working with customers worldwide. His experience spans satellite communications, telecommunications and technology ventures. He graduated from the Warsaw School of Economics (SGH) and writes about space technology, artificial intelligence, stocks and the technology companies and industries he follows. Follow Marcin Frąckiewicz on Google News, Facebook or LinkedIn.

Equifax Stock Jumps as Earnings Beat Forecasts – Guidance Hiked, Analysts See Upside

Equifax Stock Jumps as Earnings Beat Forecasts – Guidance Hiked, Analysts See Upside

Equifax’s stock has been range-bound in recent weeks, hovering in the low-$230s per share. It closed at $231.12 on Oct. 20investing.com, and despite a solid year-to-date performance in 2025, shares remain about 15% lower than a year agoinvesting.com. Elevated interest rates and recession worries weighed on credit industry stocks earlier this year. However, sentiment has improved recently as the Federal Reserve’s policy outlook turned more dovish this fall and tech-focused stocks rebounded. Equifax stock is up roughly 2% for 2025 so far, outperforming some peers, and has climbed about 50% over the past five years.
21 October 2025
··
Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health Stock Soars on Massive Q3 Earnings Beat – What It Means for Investors

Elevance Health posted strong third-quarter 2025 results, significantly outperforming market expectations on both profit and revenue. Adjusted earnings came in at $6.03 per share, well above the ~$4.95 analysts predictedinvesting.com. Likewise, revenue for the quarter reached $50.1 billion, surpassing the $49.3 billion consensus and growing 12% year-over-yearinvesting.com. This robust growth was fueled by higher premium yields and an expanding customer base – particularly gains in Medicare Advantage enrollments – along with contributions from recent acquisitions in Elevance’s Carelon health services unittradingview.com. These factors combined to help Elevance smash its Q3 forecasts, showcasing strong demand and pricing power in its health benefits business.
21 October 2025
····
Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher (DHR) Stock Surges on Earnings Beat as Analysts Eye Upside (Oct 21, 2025)

Danaher’s shares have been on a steady climb in recent weeks, hovering around the $208 mark as of October 21, 2025. This puts the stock roughly back to early-year levels and marks a solid rebound from its summer lows. In fact, DHR has gained about 8% over the past month and 10% over the past quarter, outpacing many peers in the life sciences sectorts2.tech. This rally suggests renewed investor interest in Danaher and its industry, possibly driven by anticipation of the Q3 earnings and optimism around new product developments.
21 October 2025
··
3M Stock Soars on Earnings Beat & Turnaround Progress – What Investors Need to Know

3M Stock Soars on Earnings Beat & Turnaround Progress – What Investors Need to Know

3M’s stock has been grinding higher in 2025 after a rough prior decade. Shares are hovering in the mid-$150s – near their highest levels of the past year, though still below pre-2020 peaks. As of the Oct. 20 close, MMM was at $154.78, having climbed about +17.5% in the past 12 monthsca.investing.com. By comparison, the S&P 500 is up roughly mid-teens percentage over a similar period. Year-to-date, 3M’s gains are in the high single digits to low teens range, depending on the baseline – a notable improvement considering the stock languished near multi-year lows around $120–$130 not long ago.
21 October 2025
··
IDFC First Bank Stock Soars 7% After Profit Surge – What’s Next for its Share Price?

IDFC First Bank Stock Soars 7% After Profit Surge – What’s Next for its Share Price?

IDFC First Bank’s stock has been on a tear, soaring about 7% in a single session after the lender delivered stellar Q2 FY2025-26 results. On October 20, the share price hit approximately ₹77 – its highest level in nearly 11 months – as investors cheered a 75% jump in quarterly profitmoneycontrol.com. This upbeat earnings surprise sparked a rally that far outpaced the broader market and peer banks. In fact, IDFC First was the top gainer among major private lenders following the Q2 results: its ~5–7% surge on the day eclipsed gains in Yes Bank and HDFC Bank, while ICICI Bank’s shares fell ~2.5% despite that bank posting profit growthlivemint.com. The exuberant reaction has brought IDFC First’s stock within touching distance of its 52-week high of around ₹78.5business-standard.combusiness-standard.com, prompting investors to ask – what’s driving this bank’s outperformance, and can it continue?
21 October 2025
·
ICICI Bank Stock at ₹1,380 Today – Analysts Eye ₹1,800 Target After Q2 Earnings Shock

ICICI Bank Stock at ₹1,380 Today – Analysts Eye ₹1,800 Target After Q2 Earnings Shock

As of October 21, 2025, ICICI Bank’s stock traded around ₹1,380 per share, slightly in the red for the daylivemint.com. The price is down about 0.5% from the previous close of ~₹1,390, continuing to linger after a sharp fall on Monday. On October 20, the stock plunged over 3% intraday, hitting lows near ₹1,389 before closing around ₹1,390.90hindustantimes.com. This drop erased gains from the prior week – ICICI had been trading above ₹1,430 last Friday before earnings. Despite the recent volatility, the stock remains up roughly 8–9% in 2025 so farlivemint.com, outperforming broader indices. It is currently about 7% below its 52-week high of ₹1,494livemint.com.
21 October 2025
·
South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

South Indian Bank Stock Soars to Record High on Q2 Earnings – Will ₹50 Be Next?

South Indian Bank’s stock price has been on fire, soaring to an all-time high this week on the back of strong earnings and bullish investor sentiment. On October 21, the scrip touched approximately ₹38.4 during the Muhurat trading session, building on the previous day’s big gainslivemint.com. At ₹38+, the share is trading at levels never seen before in the bank’s historybusinesstoday.in. For context, the stock was hovering around ₹32 just before the results – meaning it’s leapt about 15–18% in two trading sessions alone.
21 October 2025
··
Mystery Chip Stock Soars ~57,000% to ₹9,500 – RRP Semiconductor’s Frenzy Triggers Bubble Fears

Mystery Chip Stock Soars ~57,000% to ₹9,500 – RRP Semiconductor’s Frenzy Triggers Bubble Fears

RRP Semiconductor Ltd – a microcap firm virtually unheard of a year ago – has stunned the market with an eye-popping stock price surge. The company’s share price climbed from just ₹15 in April 2024 to about ₹9,300+ by October 2025, an increase of several thousand-foldenglish.mathrubhumi.com. As of October 21, 2025, RRP opened at ₹9,478 per share and immediately hit its 2% upper circuit for the dayinvesting.com. This caps a streak of consecutive upper-limit gains in recent sessions, with the stock rising roughly 2% each trading day over the past week. Year-to-date in 2025 alone, RRP’s stock has multiplied over 48-foldts2.tech, and since its listing 18 months ago it’s up about 57,000%moneycontrol.com – a virtually unheard-of return for any public company.
21 October 2025
··
Duralex Crisis Deepens: Iconic French Glassmaker Seeks €5M Lifeline from Public Investors

Duralex Crisis Deepens: Iconic French Glassmaker Seeks €5M Lifeline from Public Investors

Founded in 1945, Duralex is a household name in France, known worldwide for its nearly indestructible tempered glass cups and plates. The company is considered part of France’s industrial patrimoine – a storied legacy spanning roughly 70 years of glassmakingbfmtv.com. But that proud history has been marred by repeated crises. Over the past three decades, Duralex has endured multiple bankruptcies and rescues, as successive owners failed to modernize its factory in La Chapelle-Saint-Mesmin. By 2020, amid mounting debt, Duralex entered court-administered reorganization, and a new investor took over in 2021decideurs-cf.com.
21 October 2025
Stock Market Today 21.10.2025

Stock Market Today 21.10.2025

{“@context”:”https://schema.org”,”@type”:”LiveBlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-21-10-2025/#live”,”headline”:”Stock Market Today 21.10.2025″,”description”:”Live rolling coverage of technology news: AI, chips, gadgets, software, startups, cybersecurity, telecom, and policy.”,”datePublished”:”2025-10-21T06:00:02-04:00″,”dateModified”:”2025-10-23T06:44:02-04:00″,”coverageStartTime”:”2025-10-21T06:00:02-04:00″,”coverageEndTime”:”2025-10-23T06:44:02-04:00″,”author”:{“@type”:”Organization”,”name”:”TechStock²”},”publisher”:{“@type”:”Organization”,”name”:”TechStock²”,”logo”:{“@type”:”ImageObject”,”url”:”https://ts2.tech/wp-content/uploads/2024/02/cropped-ts2-logo-google.png”}},”inLanguage”:”en-US”,”liveBlogUpdate”:[{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-21-10-2025/#live/u/e4e7152bb08cf7a6″,”headline”:”Weatherford International Q3 Earnings Miss; Profit Drops, Revenue Declines”,”articleBody”:”Weatherford International (WFT) reported Q3 earnings of $81 million, or $1.12 per share, down from $157 million or $2.06 per share a year earlier. Analysts had expected about $1.19 per share in EPS, meaning the report missed estimates. Revenue declined 12.6% to $1.232 billion from $1.409 billion last year. The results underscore ongoing pressure on Weatherfordu0027s activity levels and markets. Overall, EPS and revenue failed to meet expectations.”,”datePublished”:”2025-10-21T19:06:13-04:00″,”dateModified”:”2025-10-21T19:06:13-04:00″,”mainEntityOfPage”:”https://ts2.tech/en/stock-market-today-21-10-2025/#u-e4e7152bb08cf7a6″,”url”:”https://ts2.tech/en/stock-market-today-21-10-2025/#u-e4e7152bb08cf7a6″},{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-21-10-2025/#live/u/186d92a4a72c8603″,”headline”:”Wall Street ends mixed as earnings lift the
21 October 2025
·
Apple Stock Soars to Record High on iPhone 17 “Supercycle” Buzz – Will the Rally Last?

Apple Stock Soars to Record High on iPhone 17 “Supercycle” Buzz – Will the Rally Last?

Apple’s share price surged to a record peak on Oct. 20 as investors piled in on upbeat news about the iPhone 17 launch. The stock jumped nearly 4%, closing around $262 – a new all-time high that eclipses the previous peak of $259 set last yearappleinsider.com. In intraday trading, AAPL reached as high as ~$264, briefly valuing the company at about $3.9 trillion, the highest ever and putting Apple within striking distance of the unprecedented $4 trillion marktradingnews.comtradingnews.com. This rally marked a sharp sentiment shift for Apple, which until recently had been lagging behind other tech giants in 2025. Even after this jump, Apple’s stock is only up roughly 5% year-to-date, far behind high-fliers like Nvidia or Microsoft that have ridden 2025’s AI stock boomts2.tech. The late-year surge has helped Apple narrow that gap, with its shares gaining about 22% over the past three months alone – outpacing the S&P 500’s ~11% gain in the same periodtradingnews.com.
20 October 2025
··
Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Therapeutics Stock Soars on Gene-Editing Buzz – Analysts Project Big Upside

Beam Therapeutics’ stock surged on Monday, Oct. 20, extending a strong upward streak. By mid-afternoon the share price hit $30.35, up 16.8% for the dayfinviz.com. This marked BEAM’s highest price since early 2024 and a dramatic rebound from its summer lows. Traders point to a bullish “golden cross” pattern on Beam’s chart – the stock’s 50-day moving average recently rose above its 200-day averagefinviz.com, a technical signal often seen as confirmation of a positive trend reversal. Zacks noted that BEAM had rallied ~6.8% over the prior four weeks leading into this golden-cross eventfinviz.com, helping shift its Zacks Rank to #2. The sharp Monday jump may have been fueled by momentum traders reacting to these technicals and upbeat analyst commentary, as well as broader sector tailwinds.
20 October 2025
·····
Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results

Celcuity Stock Skyrockets 40% to Record High on ‘Practice-Changing’ Cancer Trial Results

Celcuity’s stock price skyrocketed on October 20, 2025 after the Minneapolis-based biotech reported game-changing clinical trial results. Shares jumped from around $52 to as high as $78–$81 intradaymarketbeat.com, an approximately 40–50% single-day leap, before settling near a record high close. This surge marked a new 52-week high of $81.56marketbeat.com and lifted Celcuity’s market capitalization above $2.2 billioninvesting.com. The stunning rally came on unusually heavy trading volume as investors rushed to buy shares, propelled by news from a major cancer conference.
20 October 2025
··
Salesforce Stock Surges After $60B AI Bombshell – Here’s What’s Next (Oct 20, 2025)

Salesforce Stock Surges After $60B AI Bombshell – Here’s What’s Next (Oct 20, 2025)

After a bumpy few months, Salesforce stock has shown signs of stabilizing in October. Shares hit a multi-month low of $235.69 on Oct. 1 amid broader market weakness and lingering post-earnings worriests2.tech. That slump — roughly a 7% drop in September — was fueled by soft guidance from management on future sales, which tempered expectations despite strong last-quarter resultsts2.tech. Early in October, an alarming security scare added to jitters: a hacker group claimed to have stolen data from Salesforce clients’ databases, sparking headlines about a potential breachts2.tech. Salesforce assured that its own systems weren’t compromised, but the incident was a stark reminder of cybersecurity risks in the cloud businessts2.tech.
20 October 2025
····
GRAIL Stock Rockets on Samsung Mega-Deal and Cancer Test Breakthrough

GRAIL Stock Rockets on Samsung Mega-Deal and Cancer Test Breakthrough

GRAIL’s stock price exploded after the company announced a strategic alliance with Samsung on October 16. Under the deal, Samsung C&T will invest $110 million in GRAIL and become the exclusive distributor of the Galleri multi-cancer blood test in South Korea, with rights to expand into Japan and Singaporets2.tech. Samsung Electronics is also participating and plans to explore AI and health-data collaborations with GRAILts2.tech. This marks a major vote of confidence from one of Asia’s largest conglomerates. The partnership is expected to close by early 2026 and gives GRAIL a powerful commercialization partner in key Asian marketstradingview.com.
20 October 2025
···
Quantum Gold Rush: D-Wave (QBTS) Stock Skyrockets on Quantum Breakthroughs & Hype – What’s Next?

Quantum Gold Rush: D-Wave (QBTS) Stock Skyrockets on Quantum Breakthroughs & Hype – What’s Next?

D-Wave’s stock has been on a rollercoaster ride in recent weeks. After trading in the mid-$20s at the start of October, QBTS shares went parabolic – rocketing to a record intraday high of $46.75 on October 15. In a single session on Oct. 13, the stock jumped over 23% intraday amid a frenzy of trading volumets2.tech. By mid-October D-Wave was up nearly 300% year-to-date and an astonishing ~3,000% from one year ago, making it one of 2025’s top-performing stocks.
20 October 2025
···
IonQ Stock’s Quantum Leap: Soaring 700% in a Year, $2 B Cash Boost & Bold Plans – Bubble or Breakthrough?

IonQ Stock’s Quantum Leap: Soaring 700% in a Year, $2 B Cash Boost & Bold Plans – Bubble or Breakthrough?

IonQ’s stock seesawed on Monday amid continued volatility. After opening near $65, IONQ shares briefly spiked to about $65.50 before reversing and dipping as low as $58.80 intradaystockanalysis.com. By afternoon, the stock stabilized around $62.5, essentially flat versus last week’s closestockanalysis.com. This breather comes on the heels of a breathtaking rally: on October 13, IonQ closed at $82.59, capping a single-day +16.9% jumpts2.techts2.tech. That peak marked roughly a +75% gain year-to-date and an astonishing ~700% rise from a year agots2.tech. In fact, IONQ’s 52-week range spans from about $9 to the $80s, reflecting extreme volatility and the stock’s speculative naturets2.techts2.tech. Daily swings of 5–10% have become routine.
20 October 2025
··
Alibaba Stock Near 4-Year High as AI Ambitions Ignite Rally – Will BABA’s Surge Last?

Alibaba Stock Near 4-Year High as AI Ambitions Ignite Rally – Will BABA’s Surge Last?

Alibaba Group Holding’s U.S. shares are trading around $166 as of Monday, October 20, 2025 – hovering near their highest levels in four yearsts2.tech. The stock has roughly doubled in 2025, vastly outperforming broader indices. Year-to-date, BABA is up about 85–97% in valuets2.techbenzinga.com, making it one of the top tech rebound stories of the year. By comparison, the NYSE Composite index has gained only ~12% in 2025benzinga.com. Alibaba’s ADR price hit the mid-$170s earlier this month – territory not seen since 2019 – before a brief pullback. Over the past week, shares have been volatile but largely steady: after a mid-week dip on trade war fears, BABA rebounded and is essentially flat versus last Fridayts2.techts2.tech. In Hong Kong, Alibaba’s secondary listing similarly bounced ~5% on Monday after a sharp drop late last week, reflecting improving sentiment after initial jitters.
20 October 2025
···
1 … 282 283 284 285 286 … 419
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap Holdings

NYSE: AER 92/100
#2 BUY

Uber Technologies

NYSE: UBER 90/100
#3 BUY

Taiwan Semiconductor Manufacturing

NYSE: TSM 89/100
#4 ACCUMULATE

dLocal

NASDAQ: DLO 86/100
#5 ACCUMULATE

Tapestry

NYSE: TPR 84/100
View full portfolio
Editorial model selection. Not personalised advice.